Journal of Addiction Medicine, 8(5), 315326
Concerns about pancreatitis have emerged since GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and liraglutide (Victoza) became widely prescribed for type 2 diabetes and weight management
Tirzepatide is newer, with FDA approval for weight loss (as Zepbound) coming in late 2023
The two mechanisms are complementary: tirzepatide stops excess eating before it happens, while L-carnitine optimizes how your body processes fat already mobilized during weight loss
Allow the sanitized skin to dry, and then pull the skin taut (tight) over the region before injecting the needle
Available from: GBD 2021 Diabetes Collaborators (2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021